| Application no. and date | 10810654.3 (espacenet) (Federated) (European Patent Register), 20100820 | | Patent/reg. no. and date | DK/EP 2467140, 20160601 | | Publication date | 20120627 | | Priority no. and date | US 235947 P, 20090821, US 307569 P, 20100224 | | EP pub. no. and date |
EP 2467140 20120627 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/AP/153825 | | Inventor | COX, Charles, J., New Frontiers Science Park
Third Avenue
Harlow, Essex CM19 5AW, GB,
SPRAGGS, Colin, F., New Frontiers Science Park
Third Avenue
Harlow, Essex CM19 5AW, GB,
BING, Nan, Five Moore Drive
Durham, NC 27709, US,
BRILEY, Linda, Perry, Five Moore Drive
Durham, NC 27709, US,
BUDDE, Laura, R., Five Moore Drive
Durham, NC 27709, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C12Q 1/68 (2006.01) , G01N 33/569 (2006.01) , G01N 33/574 (2006.01) | | Title | Lapatinib til behandling af cancer | | Int. application no. | US2010046142 | | Int. publication no. | WO2011022633 | | Related patent (certificate) | | | Status | Afkaldt | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
